cbdMD’s CBD PM and CBD Freeze Awarded 2020 Product of the Year
Summary: Both products, CBD PM and CBD Freeze Roller, have been voted the 2020 Product of the Year winner in the CBD Sleep Aid and CBD Topical categories.
CHARLOTTE, NC (February 7, 2020) – cbdMD, Inc. a nationally recognized consumer cannabidiol (CBD) brand (NYSE American: YCBD), is pleased to announce that their CBD PM and CBD Freeze Roller products have been voted the winner of the prestigious 2020 Product of the Year award in the CBD Sleep Aid and CBD Topical categories, respectively.
This is America’s largest consumer-voted award for product innovation, as 40,000 voters participated in an online study organized by independent research firm Kantar Media Group. cbdMD Chief Marketing Officer, Ken Cohn, accepted the award on behalf of the company during a special ceremony in New York City last night.
CBD PM is a premium sleep aid containing superior broad spectrum CBD, melatonin, and a unique blend of soothing herbs. The CBD Freeze Roller combines the pain-relieving properties of menthol with the natural power of domestically sourced CBD. This was the first year that Product of the Year USA provided a category for CBD companies. cbdMD is the first and only CBD company to win a Product of the Year award.
“We are so honored to be the first CBD company to receive a Product of the Year award for our CBD PM and CBD Freeze products,” said Ken Cohn, Chief Marketing Officer at cbdMD. “So many people put their talent and hard work into getting our products on shelves all across the country. This is a true testament to our great team at cbdMD and we’re excited to be recognized amongst the elite companies and brands that Product of the Year highlights every year.”
The Product of the Year award operates in 38 countries around the world. Beginning in March, the distinctive red “Voted Product of the Year” logo will be leveraged across all marketing channels, including product packaging, advertising, promotions, social media accounts, and brand website.
For more information on cbdMD, please visit www.cbdmd.com
cbdMD, Inc. is a nationally recognized consumer cannabidiol (CBD) brand whose current products include CBD tinctures, CBD gummies, CBD topicals, CBD bath bombs, and CBD pet products. cbdMD is also a proud partner of Bellator MMA, Life Time, Inc., and Supercross, and has one of the largest rosters of professional sports athletes who are part of “Team cbdMD.” To learn more about cbdMD and our comprehensive line of over 100 SKUs of U.S. produced, THC-free CBD products, please visit www.cbdmd.com or follow cbdMD on Instagram and Facebook, or visit one of the 4,000 retail outlets that carry cbdMD products.
About Product of the Year:
Product of the Year is the world’s largest consumer-voted award for product innovation. Established 30 years ago, POY currently operates in 38 countries with the same purpose: Guide consumers to the best products in their market and reward manufacturers for quality and innovation. Product of the Year winners are backed by the votes of over 40,000 consumers in a nationally representative survey conducted by research partner Kantar TNS, a global leader in consumer research. The award is a powerful merchandising program for marketers proven to increase product sales, distribution, and awareness. Winning products are announced in February each year and receive the right to use the Product of the Year seal in marketing communications for two years. For more information, visit productoftheyearusa.com.
This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified by the use of words such as ”should,” ”may,” ”intends,” ”anticipates,” ”believes,” ”estimates,” ”projects,” ”forecasts,” ”expects,” ”plans,” and ”proposes.” These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, including, but not limited to, our ability to expand the sales of our CBD products through our partnerships, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading “Risk Factors” in cbdMD, Inc.’s Annual Report on Form 10-K for the fiscal year ended September 30, 2018, as filed with the Securities and Exchange Commission (the “SEC”) on December 12, 2018, our Quarterly Report on Form 10-Q for the period ended March 31, 2019, as filed with the SEC on May 15, 2019, our Quarterly Report on Form 10-Q for the period ended June 30, 2019, as filed with the SEC on August 14, 2019, and our other filings with the SEC. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are generally outside the control of cbdMD, Inc. and are difficult to predict. cbdMD, Inc. does not undertake any duty to update any forward-looking statements except as may be required by law. The information which appears on our websites and our social media platforms, including, but not limited to, Instagram and Facebook, is not part of this press release.